Skip to main content
. 2017 Apr 27;12(5):799–806. doi: 10.2215/CJN.09410916

Table 2.

Association of outcomes in patients with CKD with potentially preventable HACs

Potentially Preventable HACs Mortality: Index Hospitalizationa (95% CI) Mortality: Discharge to 90 da (95% CI) Incremental LOS (d),b median (95% CI) Readmission Discharge to 90 da (95% CI)
≥1 4.67 (4.17 to 5.22) 1.08 (0.94 to 1.25)c 9.86 (9.25 to 10.47) 1.24 (1.15 to 1.34)
1 3.56 (3.11 to 4.07) 1.17(0.99 to 1.38)c 7.20 (6.54 to 7.96) 1.21(1.11 to 1.32)
2–3 6.52 (5.50 to 7.73) 0.91 (0.71 to 1.18)c 12.09 (11.81 to 13.98) 1.28 (1.12 to 1.46)
4–5 10.47 (7.78 to 14.08) 0.88 (0.54 to 1.44)c 17.14 (14.94 to 19.34) 1.35 (1.04 to 1.75)
>5 18.89 (12.12 to 29.44) 1.29 (0.67 to 2.47)c 39.92 (36.54 to 43.30) 1.48 (1.00 to 219)

HAC, hospital-acquired complication; 95% CI, 95% confidence interval; LOS, length of stay.

a

Fully adjusted for age, admission type (elective versus urgent), sex, LOS, severity of CKD, nonpreventable complications, and 16 comorbid conditions.

b

Fully adjusted for age, admission type (elective versus urgent), sex, severity of CKD, nonpreventable complications, and 16 comorbid conditions. Comorbid conditions: cancer, cerebrovascular disease, congestive heart failure, chronic obstructive pulmonary disease, dementia, diabetes with complications, diabetes with no complications, HIV/AIDS, metastatic solid tumor, myocardial infarction, mild liver disease, moderate/severe liver disease, para/hemiplegia, peptic ulcer disease, peripheral vascular diseases, rheumatologic diseases; reference: admissions without HAC.

c

Nonsignificant.